沈晶 - 西南医科大学

个人简介

女，1985年9月出生，籍贯内蒙古，2013年于香港中文大学生物医学院获得博士学位，2016年1月迄今为西南医科大学副教授，研究生导师。是Current Pharmaceutical Design杂志客座编辑；Current Medicinal Chemistry, Growth Factors等杂志的特邀审稿人；美国癌症协会(American Association for Cancer Research, AACR)和欧洲肿瘤免疫学会(European Academy for Tumor Immunology, EATI)会员。2017年获得国家自然科学基金青年基金资助。近年来先后在Cancer Research（影响因子：8.556），J Control Release（影响因子：7.705）；Oncoimmunology（影响因子：7.644）等国际重要期刊发表SCI论文近30篇。工作经历 2016/01-迄今，西南医科大学，药学院，副教授 2013/08-2015/12，香港中文大学，生物医学院，博士后研究员

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Xu ZY^, Shen J^, Wang MH, Yi T, Yu YY, Zhu YX, Chen B, Chen JP, Li LF, Li MX, Zuo J, Jiang H, Zhou DX, Luan J, Xiao Z. Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer. OncoImmunology. Accepted. [Impact factor = 7.664] 2. Shen J, Li ZJ, Li LF, Lu L, Xiao Z, Wu WK, Zhang L, Li MX, Hu W, Chan KM, Cho CH. Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth. J Transl Med. 2016 Jun 24;14(1):187. [Impact factor = 3.694] 3. Shen J, Xiao Z, Wu WK, Wang MH, To KF, Chen Y, Yang W, Li SM, Shin VY, Tong JH, Kang W, Zhang L, Li M, Wang L, Lu L, Chan RLY, Wong SH, Yu J, Chan MTV, Chan FKL, Sung JJY, Cheng ASL, Cho CH. (2015). Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. Cancer Res. 15;75(4):754-65. [Impact factor = 9.329] 4. Shen J，Li WX, Xiao ZG, Zhang L, Li MX, Li LF, Hu W, Lu L, Boudreau F, Cho CH. The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons. Curr Med Chem. 2016;23(11):1131-8. [Impact factor = 3.853] 5. Shen J*, Cho CH. (2014). Cathelicidin A unique host defense peptide for gastric disorders. J Biomol Res Therapeut. 3: e126 6. Shen J, Wu WK, Ren SX, Zhang L, Chan RL, Wong CC, Lu L, Cho CH. (2013). miRNAs in Gastrointestinal and Liver Cancers: Their Perspectives and Clinical Applications. Curr Pharm Des. 19(7), 1301-1310. [Impact factor = 3.452] 7. Shen J#, Cho CH. (2013). Editorial: miRNA in the pathogenesis and therapy for gastrointestinal and hepatic cancers. Curr Pharm Des. 19(7):1179. [Impact factor = 3.452]